Fuerteventura General Hospital Secures National Certification for Intravitreal Therapy Unit
The General Hospital of Fuerteventura has achieved certification from the Spanish Society of Retina and Vitreous for its Intravitreal Therapy unit, a recognition that validates compliance with quality and safety standards in the treatment of retinal pathologies.
This accreditation places the hospital among the pioneers in the Canary Islands to obtain this quality seal, consolidating its commitment to specialized, efficient, patient‑centered healthcare.
Intravitreal therapy involves administering medication directly inside the eye. The procedure is performed under strict aseptic conditions, with topical anesthesia and in an environment prepared to guarantee patient safety. It is widely used to treat diseases such as age‑related macular degeneration, diabetic macular edema, retinal vascular occlusions, and certain intra‑ocular infections.
Since its launch in February 2017, the unit has:
- Treated 728 patients
- Administered 7,041 injections
- Served an average of 30 patients per day, depending on demand
The service is staffed by a multidisciplinary team of six ophthalmologists, nursing personnel, and auxiliary nursing technicians, who work in coordination to provide specialized care.
The certification granted by the SERV is valid for three years, until 2029, making the Majorero hospital the second centre in the Canary Islands to receive this recognition, after the Insular University Hospital Complex‑Maternal‑Child of Gran Canaria.
The health centre reminds that, in case of any visual alteration, the first step is to consult a primary‑care physician, who will assess the need for referral to a specialist. It also advises paying attention to symptoms such as flashes of light, a sudden increase in floaters, or visual distortion, which may indicate retinal problems.
With this recognition, the General Hospital of Fuerteventura strengthens its position in ophthalmology and specialized care throughout the archipelago.